SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML
PendingCombined Mark
•
Never miss important updates for SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Key Information
Ownership
TP
Address
400 Interpace Parkway, Building a
Parsippany, NJ 07054
Critical Dates
First Use Date
Mar 1, 2024
Filing Date
Nov 13, 2024
Publication Date
Not published yet
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for the treatment of autoimmune diseases
Class 10
Injectors for medical purposes, namely, medical fluid injectors
Mark Elements
Text Mark
SIMLANDI (ADALIMUMAB-RYVK) INJECTION 40MG/0.4ML
Category
Trademark
Standard Characters
No
Color Claim
Yes
Drawing/Image Description
The mark consists of Leaf design in teal and burgundy and word SIMLANDI in teal and adalimumab-ryvk in black.
Color Details
The color(s) teal, burgundy and black is/are claimed as a feature of the mark.
Design Search Codes
05.03.08
More than one leaf, including scattered leaves, bunches of leaves not attached to branches05.03.25
Leaf, single26.07.13
Diamonds, exactly two diamonds26.07.21
Diamonds that are completely or partially shadedTrademark Timeline
First Use
Filing Date
USPTO Records
No documents found for this trademark.